UMary Allen
Minyaka yonke, thina eSweden sisebenzisa izigidi eziningi ezintweni ezixosha imikhaza ukuze sivikele abangani bethu bezinja. Ngo-2016, imithamo engaphezu kwesigidi yemithi exosha imikhaza yathengiswa emakhemisi.
Ikhambi lomkhaza elidume kakhulu i-Frontline, elehliselwa entanyeni yenja futhi aliyona incwadi kadokotela. Ikhambi lesibili elidume kakhulu lomkhaza i-Bravecto yithebhulethi ehlafunwayo kadokotela. Kodwa ngokwezibalo zokuqala, imibiko engu-89 yemiphumela emibi ye-120 etholwe yi-Medical Products Agency ngo-2016 yayimayelana ne-Bravecto. Phakathi kwalezi zibalo kukhona okusolwa ukuthi mibi kakhulu futhi imiphumela emibi kakhulu.
Imiphumela emibi kakhulu
Okwamanje, idatha incane kakhulu, futhi incike kodokotela bezilwane ababika imiphumela emibi esolwayo ukuze banqume ikusasa lemithi ethile exosha imikhaza. Kodwa izindaba ezinhle ukuthi i-European Medicines Agency (EMA) okwamanje iphenya iBravecto.
NgoJuni, uphenyo kulindeleke ukuba luphothulwe, bese sithemba ukuthi sizothola ulwazi olwengeziwe mayelana nokuthi ukulungiswa kuzithinta kanjani izinja zethu. Kusesekuseni kakhulu ukuthi singasho okunye okujwayelekile mayelana namalungiselelo, kodwa njengawo wonke amalungiselelo esiwasebenzisa ezinjeni zethu, kubalulekile ukuthi siqaphe inja futhi sibheke noma yimiphi imiphumela emibi.
Kuthiwani Ngenja Yakho?
Maningi amalungiselelo okumelana nemikhaza ekuhwebeni, futhi kunzima ukwazi ukuthi iyiphi efanela inja yakho. Ngesikhathi esifanayo, imikhaza iyinkawu yangempela kubangane bethu abanemilenze emine. Wenzani ukuze uvikele inja yakho emikhazani? Ingabe uyasebenzisa into exosha imikhaza, ikhola yomkhaza, noma enye into? Ingabe uzizwa uphephile ngalelo khambi?